Cabozantinib: An evolving therapy for hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) is rising in incidence and remains a leading cause of cancer-related death. After a decade of disappointing trials following the approval of sorafenib for patients with advanced HCC, a number of tyrosine kinase inhibitors (TKIs) and monoclonal antibodies targeting angi …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
carcinoma
hepatocellular / pathology
liver neoplasms / pathology
liver neoplasms / drug therapy*
hepatocellular / drug therapy*
pmid:34029957
doi:10.1016/j.ctrv.2021.102221
anthony b el-khoueiry
diana l hanna
robin kate kelley
anilides / therapeutic use*
antineoplastic agents / therapeutic use*
pyridines / therapeutic use*
Access
Citation
ID:
267326
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
267326
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet